1.Study of diagnostic value of circRNA9226 combined with tumor markers in lung adenocarcinoma
Wei ZHOU ; Yangcong QI ; Zhangsheng ZHAO ; Lihui QIAN ; Youli MA ; Yinyu MU
China Modern Doctor 2025;63(17):16-19
Objective To investigate the value of peripheral blood circRNA9226 combined with tumor markers for the diagnosis of lung adenocarcinoma.Methods A total of 30 patients with lung adenocarcinoma who were admitted to the Affiliated Lihuili Hospital of Ningbo University from December 2022 to January 2023 were selected as case group.Additionally,twenty healthy individuals who underwent physical examinations during the same period were selected as control group.The expression levels of circRNA9226,carcinoembryonic antigen(CEA),carbohydrate antigen(CA)199,and albumin(Alb)were compared between two groups.The diagnostic efficacy of circRNA9226 and CEA for lung adenocarcinoma was evaluated by receiver operating characteristic(ROC)curve,and the correlation between circRNA9226 and other indicators was analyzed.Results The peripheral blood circRNA9226 expression levels in case group was higher than that in control group(P<0.05).The sensitivity of circRNA9226 and CEA for diagnosing lung adenocarcinoma was 83.3%and 46.7%,respectively,with specificity of 90.0%and 100.0%.Area under the curve(AUC)was 0.897 and 0.776,respectively.When both tests were combined,the sensitivity was 93.3%,accuracy was 92.0%,and AUC was 0.918,showing a significant improvement in both sensitivity and accuracy compared to single tests.The correlation analysis results showed that circRNA9226 was positively correlated with CEA concentration(r=0.371,P<0.05)and negatively correlated with Alb concentration(r=-0.548,P<0.05).Conclusion Peripheral blood circRNA9226 has advantages in distinguishing lung adenocarcinoma from healthy controls,and combined with CEA can further improve the diagnostic efficacy.
2.Study of diagnostic value of circRNA9226 combined with tumor markers in lung adenocarcinoma
Wei ZHOU ; Yangcong QI ; Zhangsheng ZHAO ; Lihui QIAN ; Youli MA ; Yinyu MU
China Modern Doctor 2025;63(17):16-19
Objective To investigate the value of peripheral blood circRNA9226 combined with tumor markers for the diagnosis of lung adenocarcinoma.Methods A total of 30 patients with lung adenocarcinoma who were admitted to the Affiliated Lihuili Hospital of Ningbo University from December 2022 to January 2023 were selected as case group.Additionally,twenty healthy individuals who underwent physical examinations during the same period were selected as control group.The expression levels of circRNA9226,carcinoembryonic antigen(CEA),carbohydrate antigen(CA)199,and albumin(Alb)were compared between two groups.The diagnostic efficacy of circRNA9226 and CEA for lung adenocarcinoma was evaluated by receiver operating characteristic(ROC)curve,and the correlation between circRNA9226 and other indicators was analyzed.Results The peripheral blood circRNA9226 expression levels in case group was higher than that in control group(P<0.05).The sensitivity of circRNA9226 and CEA for diagnosing lung adenocarcinoma was 83.3%and 46.7%,respectively,with specificity of 90.0%and 100.0%.Area under the curve(AUC)was 0.897 and 0.776,respectively.When both tests were combined,the sensitivity was 93.3%,accuracy was 92.0%,and AUC was 0.918,showing a significant improvement in both sensitivity and accuracy compared to single tests.The correlation analysis results showed that circRNA9226 was positively correlated with CEA concentration(r=0.371,P<0.05)and negatively correlated with Alb concentration(r=-0.548,P<0.05).Conclusion Peripheral blood circRNA9226 has advantages in distinguishing lung adenocarcinoma from healthy controls,and combined with CEA can further improve the diagnostic efficacy.

Result Analysis
Print
Save
E-mail